Regenesis CEO Virginia Rybski Chats with

Regenesis Biomedical’s CEO, Virginia Rybski, chats with the team at on her expereince at AdvaMed 2011 as well as shares a story of growth and progress.

About  Regenesis:

Regenesis Biomedical, Inc. is a privately held medical technology company focused on developing and marketing noninvasive tissue regenerative medicine products. Regenesis developed, patented, and now markets the Provant® Therapy System.

Customers include health care facilities and providers that serve patients treated in acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home healthcare agencies, and outpatient clinics, as well as by patients in their homes by prescription.

Regenesis Biomedical, Inc. is a values-based company dedicated to our stakeholders: Patients, Clinicians, Shareholders, Suppliers and Employees.

Learn More at

Posted in Advocacy and Regulations, AZBio News, BioScience and tagged , , .